FormFactor, Inc. (FORM) - Q3 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 27, 2025, and the nine months ended on that date. FormFactor, Inc. is a leading provider of test and measurement technologies for the semiconductor industry, operating through two segments: Probe Cards and Systems. The company operates on a 52-week fiscal year.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Revenues | $202,676 | $207,917 | $569,830 | $574,116 |
| Gross Profit | $80,626 | $84,705 | $218,087 | $234,343 |
| Gross Margin | 39.8% | 40.7% | 38.3% | 40.8% |
| Operating Income | $18,005 | $17,855 | $33,580 | $56,930 |
| Net Income | $15,656 | $18,736 | $31,143 | $59,909 |
| Diluted EPS | $0.20 | $0.24 | $0.40 | $0.76 |
| Cash & Equivalents | $97,678 | $131,519 | $97,678 | $131,519 |
| Marketable Securities | $168,351 | $169,295 | $168,351 | $169,295 |
| Total Debt (Current + Long-term) | $12,488 | $13,314 | $12,488 | $13,314 |
Note: Debt figures represent the Building Term Loan balance of $12.5 million. No amounts were outstanding under the new $150 million revolving credit facility as of September 27, 2025.
Material Changes vs. Prior Period
- Revenue Decline: Q3 revenue decreased 2.5% year-over-year, and 9M revenue decreased 0.7%. The decline was driven by weaker demand in the Foundry & Logic market (down 13.5% in Q3) due to lower PC and server microprocessor demand.
- Profitability Impact: Net income for the 9M period dropped significantly ($31.1M vs $59.9M) primarily due to the absence of a $20.3 million one-time gain from the sale of China operations recognized in the prior year.
- Margin Compression: Gross margins declined to 39.8% in Q3 (from 40.7%) and 38.3% for 9M (from 40.8%). Management attributed this to higher manufacturing costs, including increased tariffs, partially offset by favorable product mix in some areas.
- Geographic Shifts: Revenue from South Korea increased significantly (34.9% of Q3 revenue vs 20.1% prior year), while revenue from China dropped to 5.8% (from 16.6%) following the divestiture of China operations in early 2024.
- Capital Expenditures: Investing cash outflows surged to $156.5M for the 9M period, driven by a $55M purchase of a new manufacturing facility in Farmers Branch, Texas, and a $67.2M equity investment in FICT Limited.
Guidance, Outlook, and Risks
- Strategic Investments: The company purchased a 50,000 sq. ft. clean room facility in Texas for $55M, with total expected cash expenditures between $140M and $170M in fiscal 2026. Production ramp is expected late in Q4 2026.
- Equity Investment: FormFactor holds a 20% stake in FICT Limited (via HoldCo), a provider of semiconductor substrates. The investment is accounted for under the equity method. A loss of $2.3M was recorded for the 9M period.
- Debt Facilities: A new $150M revolving credit facility was secured in July 2025, maturing in 2030. The company remains compliant with covenants, including a net leverage ratio cap of 3.50:1.
- Tax Law Changes: The "One Big Beautiful Bill Act" (OBBBA) was signed into law in July 2025, repealing the capitalization of domestic R&D expenditures. This contributed to a higher effective tax rate (29.1% in Q3 vs 10.6% prior year).
- Risks: Key risks include customer concentration (SK hynix and Intel accounted for ~35% of revenue), supply chain dependencies, trade restrictions impacting China revenue, and the execution of the new Texas facility build-out.
Investor Verification Checklist
- Customer Concentration: Verify the stability of revenue from top customers SK hynix (24.5% of Q3 revenue) and Intel (17.1% of Q3 revenue).
- Texas Facility ROI: Monitor the timeline and cost overruns for the Farmers Branch, Texas facility, with $140M-$170M in expected spend in 2026.
- Tariff Impact: Assess the long-term impact of tariffs on gross margins, which management cited as a primary driver for margin compression.
- China Divestiture Aftermath: Confirm that the exclusive distribution agreement with the buyer of the China operations is sustaining revenue levels in that region despite the drop in direct sales.
- Equity Method Investment: Track the performance of the FICT Limited investment, noting the lag in reporting and the recent loss recognition.